Regular exercise can significantly reduce pain for many people with MS, offering a helpful non-drug way to feel better.
Researchers looked at 39 high-quality trials and combined results from 36 studies to see if exercise helps pain. Overall, exercise made a meaningful difference, lowering pain more than doing nothing or usual care. For people with MS, exercise showed a clear benefit, reducing pain in many studies. Exercise also helped people after stroke, sometimes with even bigger changes in pain. Very few studies tested exercise for Parkinson’s or Alzheimer’s, so we don’t have strong answers for those conditions yet.
People with MS and their caregivers should care because exercise may be a safe way to reduce pain without more medicines, like adding a tool to your toolbox. Health care providers should notice this research because they can recommend exercise plans as part of pain care, similar to prescribing a healthy habit. Families can use simple exercise routines at home or in rehab to help manage pain, like using gentle walking, stretching, or guided classes. This matters day to day: less pain can mean better sleep, easier movement, and more independence during routine tasks. Because the benefit was seen across many studies, it’s reasonable for people with MS to try tailored exercise programs while checking with their care team.
Not every type of exercise was tested the same way, so we don’t know which exact program is best for each person with MS. Most strong evidence was for MS and stroke; there were almost no quality trials for Parkinson’s or Alzheimer’s, so we can’t assume the same results for them. Always talk with your clinician before starting or changing an exercise plan, because individual health, mobility, and safety matter.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More9/1/2026
A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing
Read More9/1/2026
Long-term study shows ravulizumab greatly reduced relapses in AQP4+ NMOSD over 3+ years with expecte
Read More9/1/2026
Even without common antibodies, NMOSD can be severe and relapsing; early maintenance immune treatmen
Read More7/26/2026
A new antioxidant-like drug helped ALS mice live longer and delayed symptoms; this early work hints
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Sports medicine (Auckland, N.Z.) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.